Articles dans des revues avec comité de lecture (36)
  1. 25. Boom, A., Pochet, R., Authelet, M., Pradier, L., Borghgraef, P., Van Leuven, F., Heizmann, C. W., & Brion, J. P. (2004). Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models. Biochimica et biophysica acta, 1742(1-3), 161-168. doi:10.1016/j.bbamcr.2004.09.011
  2. 26. Hoyaux, D., Boom, A., Van Den Bosch, L., Belot, N., Martin, J.-J., Heizmann, C. W., Kiss, R., & Pochet, R. (2002). S100A6 overexpression within astrocytes associated with impaired axons from both ALS mouse model and human patients. Journal of neuropathology and experimental neurology, 61(8), 736-744.
  3. 27. Blanpain, C., Wittamer, V., Vanderwinden, J.-M., Boom, A., Renneboog, B., Lee, B., Le Poul, E., El-Asmar, L., Govaerts, C., Vassart, G., Doms, R. W., & Parmentier, M. (2001). Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways. The Journal of biological chemistry, 276(26), 23795-23804. doi:10.1074/jbc.M100583200
  4. 28. Lebeau, C., Arlt, V.-M., Schmeiser, H.-H., Boom, A., Verroust, P. J., Devuyst, O., & Beauwens, R. (2001). Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells. Kidney international, 60(4), 1332-1342. doi:10.1046/j.1523-1755.2001.00938.x
  5. 29. Boom, A., Golstein, P., Frerotte, M., Sande, J. V., & Beauwens, R. (2000). Inhibition of basolateral cAMP permeability in the toad urinary bladder. Journal of physiology, 528(1), 189-198. doi:10.1111/j.1469-7793.2000.t01-1-00189.x
  6. 30. Boom, A., Golstein, P., Frerotte, M., Van Sande, J., & Beauwens, R. (2000). Inhibition of basolateral cAMP permeability in the toad urinary bladder. Pflügers Archiv European Journal of Physiology, 440(R8).
  7. 31. Blanpain, C., Lee, B., Tackoen, M., Puffer, B., Boom, A., Libert, F., Sharron, M., Wittamer, V., Vassart, G., Doms, R. W., & Parmentier, M. (2000). Multiple nonfunctional alleles of CCR5 are frequent in various human populations. Blood, 96(5), 1638-1645.
  8. 32. Golstein, P., Boom, A., Van Geffel, J., Jacobs, P., Masereel, B., & Beauwens, R. (1999). P-glycoprotein inhibition by glibenclamide and related compounds. Pflügers Archiv, 437(5), 652-660. doi:10.1007/s004240050829
  9. 33. Boom, A., Mollereau, C., Meunier, J. C., Vassart, G., Parmentier, M., Vanderhaeghen, J.-J., & Schiffmann, S. N. (1999). Distribution of the nociceptin and nocistatin precursor transcript in the mouse central nervous system. Neuroscience, 91(3), 991-1007. doi:10.1016/S0306-4522(98)00683-6
  10. 34. De Smedt, F., Boom, A., Pesesse, X., Schiffmann, S. N., & Erneux, C. (1996). Post-translational modification of human brain type I inositol-1,4,5-trisphosphate 5-phosphatase by farnesylation. The Journal of biological chemistry, 271(17), 10419-10424. doi:10.1074/jbc.271.17.10419
  11. 35. De Smedt, F., Boom, A., Pesesse, X., Schiffmann, S. N., & Erneux, C. (1996). Post-translational modification of human brain type iinositol 1,4,5- trisphosphate 5-phosphatase by farnesylation. Biochemical Society transactions, 24(4), 623S.
  12. 36. Boom, A., Flamion, B., Abramow, M., & Beauwens, R. (1995). Drugs activating G proteins disturb cycling of ADH-dependent water channels in toad urinary bladder. The American journal of physiology, 269(2 Pt 1), C424-C434.
    13. << Précédent 1 2 3 4 5 6 Suivant >>